Collegium Pharmaceutical Inc (COLL) Insider Trading
- $4,316,951.25
- $64,483,955.44
- June 9, 2025
- Michael Thomas Heffernan
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Jan. 7, 2021 | CTO | 16,042 | $22.00 | Sell | $352,924.00 | |
| Dec. 3, 2020 | CTO | 5,967 | $19.24 | Sell | $114,805.08 | |
| Oct. 15, 2020 | EVP | 7,060 | $20.82 | Sell | $146,989.20 | |
| July 13, 2020 | EVP | 1,429 | $17.01 | Sell | $24,307.29 | |
| June 1, 2020 | CEO | 70,676 | $21.53 | Sell | $1,521,654.28 | |
| May 13, 2020 | CTO | 7,989 | $21.67 | Sell | $173,121.63 | |
| May 13, 2020 | Director | 19,254 | $21.63 | Sell | $416,464.02 | |
| May 13, 2020 | EVP | 4,434 | $22.61 | Sell | $100,252.74 | |
| Jan. 21, 2020 | Director | 295,287 | $21.93 | Sell | $6,475,643.91 | |
| Jan. 14, 2020 | EVP | 1,321 | $23.87 | Sell | $31,532.27 | |
| Nov. 8, 2019 | Director | 25,000 | $19.33 | Sell | $483,250.00 | |
| Nov. 7, 2019 | CEO | 64,821 | $18.77 | Sell | $1,216,690.17 | |
| Aug. 29, 2019 | Director | 22,106 | $11.65 | Sell | $257,534.90 | |
| July 15, 2019 | Director | 25,000 | $11.26 | Sell | $281,500.00 | |
| July 11, 2019 | EVP | 2,857 | $12.31 | Sell | $35,169.67 | |
| June 17, 2019 | Director | 25,000 | $11.37 | Sell | $284,250.00 | |
| June 3, 2019 | CEO | 7,436 | $11.59 | Sell | $86,183.24 | |
| May 31, 2019 | CEO | 5,851 | $11.52 | Sell | $67,403.52 | |
| May 15, 2019 | Director | 25,000 | $12.84 | Sell | $321,000.00 | |
| April 15, 2019 | Director | 25,000 | $15.09 | Sell | $377,250.00 | |
| March 15, 2019 | Director | 25,000 | $17.17 | Sell | $429,250.00 | |
| Feb. 15, 2019 | Director | 25,000 | $14.81 | Sell | $370,250.00 | |
| Jan. 15, 2019 | Director | 25,000 | $15.56 | Sell | $389,000.00 | |
| Dec. 17, 2018 | Director | 25,000 | $18.18 | Sell | $454,500.00 | |
| Nov. 15, 2018 | Director | 25,000 | $16.60 | Sell | $415,000.00 | |
| Oct. 15, 2018 | Director | 25,000 | $16.53 | Sell | $413,250.00 | |
| June 21, 2018 | Insider | 10,000 | $27.92 | Sell | $279,200.00 | |
| June 12, 2018 | Chairman | 150,000 | $25.27 | Sell | $3,790,500.00 | |
| June 12, 2018 | Insider | 4,096 | $27.00 | Sell | $110,592.00 | |
| June 1, 2018 | COO | 79,683 | $22.59 | Sell | $1,800,038.97 | |
| April 19, 2018 | Chairman | 44,400 | $26.00 | Sell | $1,154,400.00 | |
| Jan. 23, 2018 | Chairman | 20,000 | $25.01 | Sell | $500,200.00 | |
| Jan. 19, 2018 | Chairman | 20,000 | $22.50 | Sell | $450,000.00 | |
| Jan. 10, 2018 | Insider | 6,928 | $19.07 | Sell | $132,116.96 | |
| Dec. 8, 2017 | Major Shareholder | 1,000,000 | $17.34 | Sell | $17,340,000.00 | |
| Nov. 21, 2017 | Insider | 4,601 | $17.25 | Sell | $79,367.25 | |
| Nov. 17, 2017 | CTO | 4,029 | $17.00 | Sell | $68,493.00 | |
| Nov. 15, 2017 | CEO | 50,000 | $15.53 | Sell | $776,500.00 | |
| May 12, 2017 | Insider | 10,000 | $9.18 | Buy | $91,800.00 | |
| Aug. 12, 2016 | Director | 2,375 | $10.59 | Buy | $25,151.25 | |
| May 12, 2015 | Director | 150,000 | $12.00 | Buy | $1,800,000.00 | |
| May 12, 2015 | Major Shareholder | 200,000 | $12.00 | Buy | $2,400,000.00 |
Insiders are both buying and selling Collegium Pharmaceutical Inc stock.
The insider traders at Collegium Pharmaceutical Inc are: Michael Thomas Heffernan, Joseph Ciaffoni, Shirley R Kuhlmann, Scott Dreyer, Alison B Fleming, Colleen Tupper, Longitude Capital Partners, Ll, John Gordon Freund, Paul Brannelly, David Hirsch, Thomas B Smith, Garen G Bohlin, and John A Fallon
The most active insider trader at Collegium Pharmaceutical Inc is Michael Thomas Heffernan with 22 trades.
Longitude Capital Partners, Ll has sold the most Collegium Pharmaceutical Inc stock with a total value of $34,680,000.00.
Longitude Capital Partners, Ll has bought the most Collegium Pharmaceutical Inc stock with a total value of $4,800,000.00.
The most recent insider trade for Collegium Pharmaceutical Inc was on June 9, 2025.
The single biggest insider buy for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $2,400,000.00 on May 12, 2015.
The single biggest insider sell for Collegium Pharmaceutical Inc was from Longitude Capital Partners, Ll with a total value of $17,340,000.00 on Dec. 8, 2017.